DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
168. エーラス・ダンロス症候群
Ehlers-Danlos syndrome
Clinical trials
/
Disease details
臨床試験数
:
8
/
薬物数
:
17
- (
DrugBank
:
9
) /
標的遺伝子数
:
9
-
標的パスウェイ数
:
55
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT00190411
(
ClinicalTrials.gov
)
October 2003
13/9/2005
Celiprolol
in Patients With Ehlers-Danlos Syndrome, Vascular Type
Prevention of Vascular Complications by BetaBlocker Treatment in Vascular Ehlers-Danlos Syndrome
EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT;CHROMOSOME 2q31.2 DELETION SYNDROME
Drug:
celiprolol
;Drug:
Control
Assistance Publique - Hôpitaux de Paris
Aventis Pharmaceuticals
Completed
15 Years
65 Years
Both
54
Phase 4
France